Stephen Salloway

← Back to Brown University

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

1. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

   2007 · 4,399 citations

2. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

   2012 · 3,795 citations

3. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

   2014 · 3,309 citations

4. Alzheimer's disease

   2016 · 3,112 citations

5. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

   2016 · 3,038 citations

6. Donanemab in Early Symptomatic Alzheimer Disease

   2023 · 2,861 citations

7. Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

   2014 · 1,958 citations

8. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

   2016 · 1,906 citations

9. Revising the definition of Alzheimer's disease: a new lexicon

   2010 · 1,872 citations

10. Donanemab in Early Alzheimer’s Disease

    2021 · 1,706 citations

11. Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    2016 · 1,195 citations

12. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

    2021 · 1,046 citations

13. Lecanemab: Appropriate Use Recommendations

    2023 · 927 citations

14. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

    2019 · 922 citations

15. Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression

    2008 · 893 citations

16. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience

    2008 · 862 citations

17. Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder

    2006 · 829 citations

18. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

    2009 · 750 citations

19. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease

    2020 · 645 citations

20. Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

    2021 · 605 citations

21. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study

    2018 · 600 citations

22. The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

    2022 · 596 citations

23. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

    2018 · 588 citations

24. Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

    2010 · 573 citations

25. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network

    2016 · 539 citations

← Return to the university profile